Skip to main content
. 2023 May 2;29(5):590–595. doi: 10.14744/tjtes.2023.45383

Table 1.

Distribution of groups, demographic data, and clinical characteristics

N %
Non-perforated group 427 (78.78)
Perforated group 115 (21.22)
Male/female 361/181 (66.61/33.39)
*Age 33.88±12.84 31.00
*ASA score 1.21±0.47 1.00
*Duration of symptoms 2.06±1.43 2.00
at admission (day)
*

n is replaced by mean±SD, and % is replaced by median